Chinese Clinical Oncology

• 临床应用 • Previous Articles     Next Articles

Clinical observation of lobaplatin used for intracavitary instillation on malignant pleuroperitoneal cavity hydrops

TIAN Xin,ZHANG Zhenyong,WU Lina,WU Rong   

  1. The SecondTumor Ward of Shengjing Hospital of China Medical University
  • Received:2013-02-22 Revised:2013-05-06 Online:2013-08-31 Published:2013-08-31
  • Contact: ZHANG Zhenyong

Abstract: Objective To observe the curative effects and adverse reaction about lobaplatin used for intracavitary instillation on malignant pleuroperitoneal cavity hydrops. Methods Thirty-two patients with malignant pleuroperitoneal cavity hydrops,locationed by B-ultrasonic wave and given puncturing and inserting catheter,were given lobaplatin for intracavitary instillation,once a week,for 2 weeks,4 times at most. The curative effects and toxicity were evaluated after 2 weeks. Results Thirty-two patients were given intracavitary instillation for at least 2 times. Of all the patients, complete response(CR) was observed in 9 patients(28.1%), partial response in 15 patients(46.9%), NS in 8 patients(25.0%). The response rate(RR) was 75.0%. The RR of pleural effusion and seroperitoneum was 80.0% and 66.7%, respectively. The toxicity mainly included chest or abdominal pain,fever,low platelets and digestive tract reaction. Conclusion Lobaplatin is effective used for intracavitary instillation on malignant pleuroperitoneal cavity hydrops with mild adverse reaction,so it is worth to be popularized.

No related articles found!
Viewed
Full text
168
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 168

  From Others local
  Times 10 158
  Rate 6% 94%

Abstract
102
Just accepted Online first Issue
0 0 102
  From Others
  Times 102
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!